- call +1-201-465-4211
- email sales@mrinsights.biz
HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of 4 hours. About 90% of the injection dose is metabolized in the liver. Only about 0.1% of the dose is excreted from the biliary tract and the kidneys.
Scope of the Report:
This report focuses on the HGH Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for HGH Biosimilars in US$ by following Product Segments.: Clinical, Experiment and Others
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
The worldwide market for HGH Biosimilars is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Clinical
Experiment
Market Segment by Applications, can be divided into
Treament
Prevention
There are 15 Chapters to deeply display the global HGH Biosimilars market.
Chapter 1, to describe HGH Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of HGH Biosimilars, with sales, revenue, and price of HGH Biosimilars, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of HGH Biosimilars, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, HGH Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe HGH Biosimilars sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 HGH Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Clinical
1.2.2 Experiment
1.3 Market Analysis by Applications
1.3.1 Treament
1.3.2 Prevention
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 HGH Biosimilars Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gilead Sciences
2.2.1 Business Overview
2.2.2 HGH Biosimilars Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Gilead Sciences HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pacira
2.3.1 Business Overview
2.3.2 HGH Biosimilars Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pacira HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sun Pharmaceutical
2.4.1 Business Overview
2.4.2 HGH Biosimilars Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sun Pharmaceutical HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Luye Pharma
2.5.1 Business Overview
2.5.2 HGH Biosimilars Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Luye Pharma HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sigma-Tau Group
2.6.1 Business Overview
2.6.2 HGH Biosimilars Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sigma-Tau Group HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Fudan-Zhangjiang
2.7.1 Business Overview
2.7.2 HGH Biosimilars Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Fudan-Zhangjiang HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teva Pharmaceutical
2.8.1 Business Overview
2.8.2 HGH Biosimilars Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceutical HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 CSPC
2.9.1 Business Overview
2.9.2 HGH Biosimilars Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CSPC HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
2.10.1 Business Overview
2.10.2 HGH Biosimilars Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Kingond Pharm
2.11.1 Business Overview
2.11.2 HGH Biosimilars Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Kingond Pharm HGH Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global HGH Biosimilars Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global HGH Biosimilars Sales and Market Share by Manufacturer (2016-2017)
3.2 Global HGH Biosimilars Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 HGH Biosimilars Manufacturer Market Share in 2017
3.3.2 Top 6 HGH Biosimilars Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global HGH Biosimilars Market Analysis by Regions
4.1 Global HGH Biosimilars Sales, Revenue and Market Share by Regions
4.1.1 Global HGH Biosimilars Sales and Market Share by Regions (2013-2018)
4.1.2 Global HGH Biosimilars Revenue and Market Share by Regions (2013-2018)
4.2 North America HGH Biosimilars Sales and Growth Rate (2013-2018)
4.3 Europe HGH Biosimilars Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific HGH Biosimilars Sales and Growth Rate (2013-2018)
4.5 South America HGH Biosimilars Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa HGH Biosimilars Sales and Growth Rate (2013-2018)
5 North America HGH Biosimilars by Countries
5.1 North America HGH Biosimilars Sales, Revenue and Market Share by Countries
5.1.1 North America HGH Biosimilars Sales and Market Share by Countries (2013-2018)
5.1.2 North America HGH Biosimilars Revenue and Market Share by Countries (2013-2018)
5.2 United States HGH Biosimilars Sales and Growth Rate (2013-2018)
5.3 Canada HGH Biosimilars Sales and Growth Rate (2013-2018)
5.4 Mexico HGH Biosimilars Sales and Growth Rate (2013-2018)
6 Europe HGH Biosimilars by Countries
6.1 Europe HGH Biosimilars Sales, Revenue and Market Share by Countries
6.1.1 Europe HGH Biosimilars Sales and Market Share by Countries (2013-2018)
6.1.2 Europe HGH Biosimilars Revenue and Market Share by Countries (2013-2018)
6.2 Germany HGH Biosimilars Sales and Growth Rate (2013-2018)
6.3 UK HGH Biosimilars Sales and Growth Rate (2013-2018)
6.4 France HGH Biosimilars Sales and Growth Rate (2013-2018)
6.5 Russia HGH Biosimilars Sales and Growth Rate (2013-2018)
6.6 Italy HGH Biosimilars Sales and Growth Rate (2013-2018)
7 Asia-Pacific HGH Biosimilars by Countries
7.1 Asia-Pacific HGH Biosimilars Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific HGH Biosimilars Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific HGH Biosimilars Revenue and Market Share by Countries (2013-2018)
7.2 China HGH Biosimilars Sales and Growth Rate (2013-2018)
7.3 Japan HGH Biosimilars Sales and Growth Rate (2013-2018)
7.4 Korea HGH Biosimilars Sales and Growth Rate (2013-2018)
7.5 India HGH Biosimilars Sales and Growth Rate (2013-2018)
7.6 Southeast Asia HGH Biosimilars Sales and Growth Rate (2013-2018)
8 South America HGH Biosimilars by Countries
8.1 South America HGH Biosimilars Sales, Revenue and Market Share by Countries
8.1.1 South America HGH Biosimilars Sales and Market Share by Countries (2013-2018)
8.1.2 South America HGH Biosimilars Revenue and Market Share by Countries (2013-2018)
8.2 Brazil HGH Biosimilars Sales and Growth Rate (2013-2018)
8.3 Argentina HGH Biosimilars Sales and Growth Rate (2013-2018)
8.4 Colombia HGH Biosimilars Sales and Growth Rate (2013-2018)
9 Middle East and Africa HGH Biosimilars by Countries
9.1 Middle East and Africa HGH Biosimilars Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa HGH Biosimilars Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa HGH Biosimilars Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia HGH Biosimilars Sales and Growth Rate (2013-2018)
9.3 UAE HGH Biosimilars Sales and Growth Rate (2013-2018)
9.4 Egypt HGH Biosimilars Sales and Growth Rate (2013-2018)
9.5 Nigeria HGH Biosimilars Sales and Growth Rate (2013-2018)
9.6 South Africa HGH Biosimilars Sales and Growth Rate (2013-2018)
10 Global HGH Biosimilars Market Segment by Type
10.1 Global HGH Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global HGH Biosimilars Sales and Market Share by Type (2013-2018)
10.1.2 Global HGH Biosimilars Revenue and Market Share by Type (2013-2018)
10.2 Clinical Sales Growth and Price
10.2.1 Global Clinical Sales Growth (2013-2018)
10.2.2 Global Clinical Price (2013-2018)
10.3 Experiment Sales Growth and Price
10.3.1 Global Experiment Sales Growth (2013-2018)
10.3.2 Global Experiment Price (2013-2018)
11 Global HGH Biosimilars Market Segment by Application
11.1 Global HGH Biosimilars Sales Market Share by Application (2013-2018)
11.2 Treament Sales Growth (2013-2018)
11.3 Prevention Sales Growth (2013-2018)
12 HGH Biosimilars Market Forecast (2018-2023)
12.1 Global HGH Biosimilars Sales, Revenue and Growth Rate (2018-2023)
12.2 HGH Biosimilars Market Forecast by Regions (2018-2023)
12.2.1 North America HGH Biosimilars Market Forecast (2018-2023)
12.2.2 Europe HGH Biosimilars Market Forecast (2018-2023)
12.2.3 Asia-Pacific HGH Biosimilars Market Forecast (2018-2023)
12.2.4 South America HGH Biosimilars Market Forecast (2018-2023)
12.2.5 Middle East and Africa HGH Biosimilars Market Forecast (2018-2023)
12.3 HGH Biosimilars Market Forecast by Type (2018-2023)
12.3.1 Global HGH Biosimilars Sales Forecast by Type (2018-2023)
12.3.2 Global HGH Biosimilars Market Share Forecast by Type (2018-2023)
12.4 HGH Biosimilars Market Forecast by Application (2018-2023)
12.4.1 Global HGH Biosimilars Sales Forecast by Application (2018-2023)
12.4.2 Global HGH Biosimilars Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure HGH Biosimilars Picture
Table Product Specifications of HGH Biosimilars
Figure Global Sales Market Share of HGH Biosimilars by Types in 2017
Table HGH B
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
